| Prevention | |
| Public Education in Skin Cancer World-Wide | p. 3 |
| UV Protection and Skin Cancer | p. 7 |
| UV Protection by Clothes | |
| Role of Clothes in Sun Protection | p. 15 |
| Sun Protective Clothing: 5 Years of Experience in Australia | p. 26 |
| European Standards for Protective Apparel Against UV Radiation | p. 35 |
| American Standards for UV-Protective Textiles | p. 42 |
| Activities of CIE DIV-6 (Photobiology and Photochemistry) in UV Protection and Clothing | p. 48 |
| Comparison of Methods: Determination of UV Protection of Clothing | p. 55 |
| Improving UV Protection by Clothing - Recent Developments | p. 62 |
| Dress up for Sun Protection/Creation of Public Awareness | p. 70 |
| Melanoma | |
| Pathogenesis | |
| The Precursors of Malignant Melanoma | p. 75 |
| Interferon-[alpha] Sensitivity in Melanoma Cells: Detection of Potential Response Marker Genes | p. 85 |
| Molecular Cytogenetics as a Diagnostic Tool for Typing Melanocytic Tumors | p. 92 |
| Loss of Heterozygosity and Microsatellite Instability in Acquired Melanocytic Nevi: Towards a Molecular Definition of the Dysplastic Nevus | p. 100 |
| Epidemiology | |
| The Changing Incidence and Mortality of Melanoma in Australia | p. 113 |
| Diagnostic | |
| Why Is Epiluminescence Microscopy Important? | p. 125 |
| Sentinel Node Biopsy: Not Only a Staging Tool? | p. 133 |
| Therapy | |
| The Impact of Surgery on the Course of Melanoma | p. 151 |
| Perspectives of Pegylated Interferon Use in Dermatological Oncology | p. 158 |
| Dendritic Cell Vaccination for the Treatment of Skin Cancer | p. 165 |
| Gene-based Immunotherapy of Skin Cancers | p. 170 |
| Cytokine-Fusion-Protein-Treatment | p. 185 |
| Cytotoxic T-cell Induction in Metastatic Melanoma Patients Undergoing Recombinant Vaccinia Virus-based Immuno-gene Therapy | p. 195 |
| Follow-up | |
| A Rational Approach to the Follow-up of Melanoma Patients | p. 205 |
| Epithelial Skin Tumors | |
| Therapy | |
| Micrographic Surgery of Basal Cell Carcinomas of the Head | p. 219 |
| Repair of Cutaneous Defects After Skin Cancer Surgery | p. 225 |
| Radiotherapy of Skin Tumors | p. 234 |
| Photodynamic Therapy and Fluorescence Diagnosis of Skin Cancers | p. 240 |
| Intralesional Interferon in Basal Cell Carcinoma: How Does It Work? | p. 246 |
| Epithelial Malignancies in Organ Transplant Patients: Clinical Presentation and New Methods of Treatment | p. 251 |
| New Treatment Modalities for Basal Cell Carcinoma | p. 259 |
| Lymphoma | |
| Pathogenesis | |
| From Inflammation to Neoplasia: New Concepts in the Pathogenesis of Cutaneous Lymphomas | p. 271 |
| Clinical Presentations | |
| Cutaneous Lymphomas and Pseudolymphomas: Newly Described Entities | p. 283 |
| Clinical Aspects and Pathology of Primary Cutaneous B-Cell Lymphomas | p. 294 |
| Diagnosis | |
| Modern Diagnosis of Cutaneous Lymphoma | p. 303 |
| Therapy | |
| Treatment of Cutaneous T Cell Lymphoma: 2001 | p. 309 |
| New Biologic Agents for the Treatment of Cutaneous T-Cell Lymphoma | p. 321 |
| Mesenchymal Tumors | |
| Etiology and Pathogenesis of Kaposi's Sarcoma | p. 331 |
| Connective Tissue Tumors | p. 343 |
| Psychosocial Aspects | |
| How to Identify Patients in Need of Psychological Intervention | p. 351 |
| Psychotherapeutic Interventions in Melanoma Patients | p. 362 |
| Subject Index | p. 371 |
| Table of Contents provided by Syndetics. All Rights Reserved. |
